Tosymra® is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: Use only if a clear diagnosis of migraine has been established. Tosymra® is not indicated for the prevention of migraine or treatment of cluster headache.

Tosymra® is contraindicated in patients with a history of hemiplegic or basilar migraine. This is not the only contraindication for Tosymra®.

Fast, ready-to-use migraine pain relief1-3

10 minutes

Tosymra® delivers migraine pain relief in as little as 10 minutes with just one spray for some patients (13% vs. 5% for placebo).*1-3


Tosymra® uses the science of Intravail®

Tosymra® is the first and only triptan nasal spray to use the novel ingredient Intravail® to enhance drug absorption across the nasal mucosa.4

Eligible, commercially insured patients may pay as little as $0 per prescription, per month

Tosymra® is simple to administer

See the Instructions for Use.

Single-use, 10 mg dosage

Fine mist-like spray

Discreet size can be
taken anywhere

Want more information?

Sign up today to learn more about Tosymra®.

    *All fields required.

    Privacy Policy and Authorization

    By clicking the submit button below, you consent to the use by Tonix Medicines, Inc. and its third parties of the information you have provided to periodically send you information about Tosymra® or other products and promotions.

    Tonix Medicines, Inc. and its third parties use the information you provide for legitimate business purposes only and will not sell, share, or otherwise distribute your personal information to third parties. By joining, you acknowledge that your consent to receive automated messages is not required as a condition to purchase goods and services.